期刊文献+

伯基特淋巴瘤发病机制的研究进展 被引量:2

Research advances in pathogenesis of Burkitt lymphoma
下载PDF
导出
摘要 伯基特淋巴瘤(Burkitt lymphoma,BL)是一种高度侵袭性非霍奇金淋巴瘤,是增长最快的恶性肿瘤之一。BL病因和发病机制尚未完全阐明,既往研究表明BL可能与c-myc易位等有关。近些年对BL病因学的研究逐渐深入,在基因突变和表观调控领域发现了一些新的致瘤机制。本综述将从基因突变和表观调控角度阐述BL发病机制的研究进展。 Burkitt lymphoma (BL) is a type of highly invasive non-Hodgkin’s lymphoma and one of the most rapidly growing malignant tumors. The etiology and pathogenesis of BL have not been fully elucidated. Previous studies have shown that BL may be related to c-myc translocation. The etiology of BL has been thoroughly studied in recent years, and some new tumorigenic mechanisms have been found in the field of gene mutation and epigenetic regulation. The aim of this review is to elucidate the pathogenesis of BL from the perspective of gene mutation and epigenetic regulation.
作者 刘文凤 邓欢 颉鸿笙 郑祝莉 王芸芸 LIU Wenfeng;DENG Huan;XIE Hongsheng;ZHENG Zhuli;WANG Yunyun(First Affiliated Hospital of Nanchang University,Nanchang 330006,China)
出处 《中国比较医学杂志》 CAS 北大核心 2019年第10期122-125,共4页 Chinese Journal of Comparative Medicine
基金 江西省教育厅科学技术研究计划项目(GJJ160240)
关键词 伯基特淋巴瘤 基因突变 表观调控 Burkitt lymphoma gene mutation epigenetic regulation pathogenesis
  • 相关文献

参考文献3

二级参考文献55

  • 1Janka GE. Hemophagocytie syndromes. Blood Rev, 2007, 21 : 245 -253.
  • 2Ishii E, Oh- S, Imashuku S, et aL Nationwide smvey d hemophagocytic lymphohisiocytosis in Japan. Int J Hematol, 2007, 86:58-65.
  • 3Chuang HC,Lay JD,Chuang SE,et al. Epstein- Barr vires (EBV) latent memhraneprotein- 1 down regulales tumor necrosis factor- alpha (TNF- alpha) receptor- 1 and confers resistance to TNF-alpha induced apoptosis in T calls: implication for the progression to T cell lymphoma in EBV- associated hemophagocytic syndrome. Am J Pathol, 2007, 170:1607-1617.
  • 4Chuang HC, Wang JM, Hsieh WC, et cd. Up regulation of activating transcription factor- 5 suppresses SAP expression to activate T cells in hemophagocytic syndrome associated with Epstein- Barr virus infection and immune disorders. Am J Pathol, 2008, 173:1397-1405.
  • 5Carbone A, Gloghini A, Dotti G. EBV-associated lymphoprolifemtivc disorders: classification and treatment. Oncologist, 2008, 13: 577-585.
  • 6Sato E, Ohga S, Kuroda H, et al. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr vlrus-associated T/natural killer-cell lymphoproliferative disease in Japan. Am J Hematol, 2008, 83:721-727.
  • 7Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood, 2001,98:280-286.
  • 8Piccaluga PP, Gazzola A, Agostinelli C, et al. Pathobiology of Epstein-Barr virus-driven peripheral T-cell lymphomas. Semin Diagu Pathol, 2011, 28:234-244.
  • 9Yarnanaka Y, Tagawa H, Takahashi N, etal. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukcmia. Blood, 2009, 114: 3265-3275.
  • 10Morrison JA, Gulley ML, Pathmanathan R, etal. Differential signaling pathways are activated in the Epstein-Ban" viros-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res, 2004, 64:5251-5260.

共引文献12

同被引文献12

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部